Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.29HKD
−697.54 MHKD
805.36 MHKD
938.28 M
About INNOCARE PHARMA LIMITED
Sector
CEO
Jisong Cui
Headquarters
Beijing
Website
Founded
2015
FIGI
BBG00S9VV4P0
InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 9969 is 6.85 HKD — it has increased by 1.62% in the past 24 hours. Watch INNOCARE PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange INNOCARE PHARMA LTD stocks are traded under the ticker 9969.
9969 stock has fallen by −0.14% compared to the previous week, the month change is a 9.19% rise, over the last year INNOCARE PHARMA LTD has showed a 6.20% increase.
We've gathered analysts' opinions on INNOCARE PHARMA LTD future price: according to them, 9969 price has a max estimate of 14.23 HKD and a min estimate of 5.92 HKD. Watch 9969 chart and read a more detailed INNOCARE PHARMA LTD stock forecast: see what analysts think of INNOCARE PHARMA LTD and suggest that you do with its stocks.
9969 reached its all-time high on Jul 19, 2021 with the price of 32.05 HKD, and its all-time low was 4.03 HKD and was reached on Apr 19, 2024. View more price dynamics on 9969 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
9969 stock is 4.35% volatile and has beta coefficient of 1.03. Track INNOCARE PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is INNOCARE PHARMA LTD there?
Today INNOCARE PHARMA LTD has the market capitalization of 9.85 B, it has decreased by −3.49% over the last week.
Yes, you can track INNOCARE PHARMA LTD financials in yearly and quarterly reports right on TradingView.
INNOCARE PHARMA LTD is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
9969 net income for the last quarter is −128.93 M HKD, while the quarter before that showed −154.93 M HKD of net income which accounts for 16.78% change. Track more INNOCARE PHARMA LTD financial stats to get the full picture.
No, 9969 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 1.09 K employees. See our rating of the largest employees — is INNOCARE PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCARE PHARMA LTD EBITDA is −626.12 M HKD, and current EBITDA margin is −83.53%. See more stats in INNOCARE PHARMA LTD financial statements.
Like other stocks, 9969 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCARE PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOCARE PHARMA LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOCARE PHARMA LTD stock shows the neutral signal. See more of INNOCARE PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.